ANDA 63350, held by Hospira. Amikacin Sulfate.
As of Nov 16, 2026, ANDA 63350 (Amikacin Sulfate), held by Hospira, was first approved by FDA on Jul 30, 1993, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 30, 1993 | Original application | Approved | None posted |
| Amikacin SulfateEQ 50MG BASE/ML · injectable;injection | Amikacin Sulfate | Discontinued |
| Amikacin SulfateEQ 250MG BASE/ML · injectable;injection | Amikacin Sulfate | Discontinued |
| Sep 17, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Jul 1, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Jul 10, 1997 | Supplement 1Manufacturing | Approved | None posted |
| Jul 30, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters